{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:26:02Z","timestamp":1789971962086,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T00:00:00Z","timestamp":1226620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to differentiate between NASH and non-progressive NAFLD on the basis of the clinical findings alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>In this study we investigated the clinical usefulness of plasma Pentraxin3 (PTX3) levels to predict NASH. Plasma PTX3 was measured in 70 patients with histologically verified NAFLD (28 with non-NASH and 42 with NASH) and 10 healthy control subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The plasma PTX3 level was significantly higher in the NASH cases than in the non-NASH cases (p = 0.0021) and control subjects (p = 0.045). And the plasma PTX3 level was significantly higher in the stages 3\u20134 NAFLD cases than in the stages 0\u20132 NAFLD cases (p &lt; 0.0001). The PTX3 values were closely correlated with the stages of liver fibrosis (p &lt; 0.0001, Kruskal-Wallis test). To detect NASH compared with non-NASH, the area under the curve for plasma PTX3 were 0.755, and to detect stages 3\u20134 NAFLD compared with stages 0\u20132 NAFLD, the area under the curve for plasma PTX3 were 0.850.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This is the first study to demonstrate consistent and profound elevation of plasma PTX3 levels in NASH in comparison with non-NASH. The results suggest that plasma PTX3 levels may not only be laboratory values that differentiate NASH from non-NASH, but marker of the severity of hepatic fibrosis in NASH.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-230x-8-53","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T07:47:40Z","timestamp":1226994460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)"],"prefix":"10.1186","volume":"8","author":[{"given":"Masato","family":"Yoneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kirikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Inamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Nozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Maeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Aburatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,14]]},"reference":[{"key":"286_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"18","author":"P Angulo","year":"2002","unstructured":"Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 18: 1221-31.","journal-title":"N Engl J Med"},{"key":"286_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1046\/j.1440-1746.2003.02989.x","volume":"18","author":"GC Farrell","year":"2003","unstructured":"Farrell GC: Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?. J Gastroenterol Hepatol. 2003, 18: 124-38.","journal-title":"J Gastroenterol Hepatol"},{"key":"286_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/0016-5085(88)90183-7","volume":"95","author":"AM Diehl","year":"1988","unstructured":"Diehl AM, Goodman Z, Ishak KG: Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1988, 95: 1056-62.","journal-title":"Gastroenterology"},{"key":"286_CR4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980, 55: 434-8.","journal-title":"Mayo Clin Proc"},{"key":"286_CR5","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.510300604","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, Keach JC, Batts KP, Lindor KD: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999, 30: 1356-62.","journal-title":"Hepatology"},{"key":"286_CR6","first-page":"823","volume":"26","author":"JF Cadranel","year":"2002","unstructured":"Cadranel JF: Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future. Gastroenterol Clin Biol. 2002, 26: 823-824.","journal-title":"Gastroenterol Clin Biol"},{"key":"286_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3748\/wjg.v11.i2.255","volume":"11","author":"H Sakugawa","year":"2005","unstructured":"Sakugawa H, Nakayoshi T, Kobashigawa K, Yamashiro T, Maeshiro T, Miyagi S, Shiroma J, Toyama A, Nakayoshi T, Kinjo F, Saito A: Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2005, 11: 255-9.","journal-title":"World J Gastroenterol"},{"key":"286_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","volume":"118","author":"V Ratziu","year":"2000","unstructured":"Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T: Liver fibrosis in overweight patients. Gastroenterology. 2000, 118: 1117-23.","journal-title":"Gastroenterology"},{"key":"286_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1386-6346(02)00246-2","volume":"24","author":"M Shimada","year":"2002","unstructured":"Shimada M, Hashimoto E, Kaneda H, Noguchi S, Hayashi N: Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res. 2002, 24: 429-438.","journal-title":"Hepatol Res"},{"key":"286_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00535-007-2060-x","volume":"42","author":"M Yoneda","year":"2007","unstructured":"Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A: High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol. 2007, 42: 573-82.","journal-title":"J Gastroenterol"},{"key":"286_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-2776(08)60379-X","volume":"34","author":"MB Pepys","year":"1983","unstructured":"Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983, 34: 141-212.","journal-title":"Adv Immunol"},{"key":"286_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda C, Bottazzi B, Bastone A, Mantovani A: Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005, 23: 337-66.","journal-title":"Annu Rev Immunol"},{"key":"286_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1189\/jlb.0905493","volume":"79","author":"A Doni","year":"2006","unstructured":"Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A: Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol. 2006, 79: 797-802.","journal-title":"J Leukoc Biol"},{"key":"286_CR14","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1016\/S0021-9258(18)41653-5","volume":"267","author":"F Breviario","year":"1992","unstructured":"Breviario F, d'Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, Saccone S, Marzella R, Predazzi V, Rocchi M: Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem. 1992, 267: 22190-7.","journal-title":"J Biol Chem"},{"key":"286_CR15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.150.5.1804","volume":"150","author":"GW Lee","year":"1993","unstructured":"Lee GW, Lee TH, Vilcek J: TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. J Immunol. 1993, 150: 1804-12.","journal-title":"J Immunol"},{"key":"286_CR16","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.V87.5.1862.1862","volume":"87","author":"M Introna","year":"1996","unstructured":"Introna M, Alles VV, Castellano M, Picardi G, De Gioia L, Bottazzai B, Peri G, Breviario F, Salmona M, De Gregorio L, Dragani TA, Srinivasan N, Blundell TL, Hamilton TA, Mantovani A: Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood. 1996, 87: 1862-72.","journal-title":"Blood"},{"key":"286_CR17","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","volume":"84","author":"VV Alles","year":"1994","unstructured":"Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A: Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood. 1994, 84: 3483-93.","journal-title":"Blood"},{"key":"286_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1194\/jlr.M200382-JLR200","volume":"44","author":"A Abderrahim-Ferkoune","year":"2003","unstructured":"Abderrahim-Ferkoune A, Bezy O, Chiellini C, Maffei M, Grimaldi P, Bonino F, Moustaid-Moussa N, Pasqualini F, Mantovani A, Ailhaud G, Amri EZ: Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. J Lipid Res. 2003, 44: 994-1000.","journal-title":"J Lipid Res"},{"key":"286_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2004.03.020","volume":"175","author":"M Klouche","year":"2004","unstructured":"Klouche M, Peri G, Knabbe C, Eckstein HH, Schmid FX, Schmitz G, Mantovani A: Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis. 2004, 175: 221-8.","journal-title":"Atherosclerosis"},{"key":"286_CR20","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","volume":"44","author":"F Fazzini","year":"2001","unstructured":"Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E, D'Auria F, Praderio L, Ciboddo G, Sabbadini MG, Manfredi AA, Mantovani A, Querini PR: PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 2001, 44: 2841-50.","journal-title":"Arthritis Rheum"},{"key":"286_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","volume":"102","author":"G Peri","year":"2000","unstructured":"Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, Pizzetti F, Maggioni AP, Moccetti T, Metra M, Cas LD, Ghezzi P, Sipe JD, Re G, Olivetti G, Mantovani A, Latini R: PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation. 2000, 102: 636-41.","journal-title":"Circulation"},{"key":"286_CR22","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","volume":"110","author":"R Latini","year":"2004","unstructured":"Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A, Lipid Assessment Trial Italian Network (LATIN) Investigators: Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2004, 110: 2349-54.","journal-title":"Circulation"},{"key":"286_CR23","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","volume":"29","author":"B Muller","year":"2001","unstructured":"Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A: Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med. 2001, 29: 1404-7.","journal-title":"Crit Care Med"},{"key":"286_CR24","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1053\/gast.2002.36572","volume":"123","author":"AJ Sanyal","year":"2002","unstructured":"Sanyal AJ: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002, 123: 1705-25.","journal-title":"Gastroenterology"},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ahj.2007.08.013","volume":"155","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, Sagara M, Kubota I: Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J. 2008, 155: 75-81.","journal-title":"Am Heart J"},{"issue":"9","key":"286_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ncprheum0290","volume":"2","author":"MS Kravitz","year":"2006","unstructured":"Kravitz MS, Shoenfeld Y: Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic disease?. Nat Clin Pract Rheumatol. 2006, 2 (9): 481-490.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"286_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5551\/jat.11.62","volume":"11","author":"S Morikawa","year":"2004","unstructured":"Morikawa S, Takabe W, Mataki C, Wada Y, Izumi A, Saito Y, Hamakubo T, Kodama T: Global analysis of RNA expression profile in human vascular cells treated with statins. J Atheroscler Thromb. 2004, 11: 62-72.","journal-title":"J Atheroscler Thromb"},{"key":"286_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-9.","journal-title":"Diabetologia"},{"key":"286_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1148\/radiology.211.1.r99ap15283","volume":"211","author":"T Yoshizumi","year":"1999","unstructured":"Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, Matsuzawa Y: Abdominal fat: standardized technique for measurement at CT. Radiology. 1999, 211: 283-286.","journal-title":"Radiology"},{"key":"286_CR30","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/hep.1840220616","volume":"22","author":"MR Teli","year":"1995","unstructured":"Teli MR, James OF, Burt AD, Bennett MK, Day CP: The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995, 22: 1714-9.","journal-title":"Hepatology"},{"key":"286_CR31","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999, 116: 1413-9.","journal-title":"Gastroenterology"},{"key":"286_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/jhep.2003.50320","volume":"38","author":"JM Hui","year":"2003","unstructured":"Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J: Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 2003, 38: 420-7.","journal-title":"Hepatology"},{"key":"286_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2001-12925","volume":"21","author":"EM Brunt","year":"2001","unstructured":"Brunt EM: Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001, 21: 3-16.","journal-title":"Semin Liver Dis"},{"issue":"Suppl 3","key":"286_CR34","doi-asserted-by":"publisher","first-page":"S385","DOI":"10.1046\/j.1440-1746.17.s3.32.x","volume":"17","author":"AJ Sanyal","year":"2002","unstructured":"Sanyal AJ: Treatment of non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002, 17 (Suppl 3): S385-S388.","journal-title":"J Gastroenterol Hepatol"},{"key":"286_CR35","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","volume":"19","author":"SH Park","year":"2004","unstructured":"Park SH, Kim BI, Yun JW, Kim JW, Park DI, Cho YK, Sung IK, Park CY, Sohn CI, Jeon WK, Kim H, Rhee EJ, Lee WY, Kim SW: Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004, 19: 694-8.","journal-title":"J Gastroenterol Hepatol"},{"key":"286_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","volume":"21","author":"SH Park","year":"2006","unstructured":"Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI: Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006, 21: 138-43.","journal-title":"J Gastroenterol Hepatol"},{"key":"286_CR37","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2337\/diabetes.54.11.3140","volume":"54","author":"AJ Hanley","year":"2005","unstructured":"Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB, Haffner SM: Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005, 54: 3140-7.","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"286_CR38","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S0264-410X(03)00199-3","volume":"21","author":"A Mantovani","year":"2003","unstructured":"Mantovani A, Garlanda C, Bottazzi B: Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine. 2003, 21 (Suppl 2): S43-7.","journal-title":"Vaccine"},{"key":"286_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda C, Bottazzi B, Bastone A, Mantovani A: Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005, 23: 337-66.","journal-title":"Annu Rev Immunol"},{"key":"286_CR40","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","volume":"34","author":"J Crespo","year":"2001","unstructured":"Crespo J, Cay\u00f3n A, Fern\u00e1ndez-Gil P, Hern\u00e1ndez-Guerra M, Mayorga M, Dom\u00ednguez-D\u00edez A, Fern\u00e1ndez-Escalante JC, Pons-Romero F: Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001, 34: 1158-63.","journal-title":"Hepatology"},{"issue":"8 Suppl Proceed","key":"286_CR41","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1097\/01.ALC.0000134410.42980.5E","volume":"28","author":"Y Nozaki","year":"2004","unstructured":"Nozaki Y, Saibara T, Nemoto Y, Ono M, Akisawa N, Iwasaki S, Hayashi Y, Hiroi M, Enzan H, Onishi S: Polymorphisms of interleukin-1 beta and beta 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis. Alcohol Clin Exp Res. 2004, 28 (8 Suppl Proceedings): 106S-110S.","journal-title":"Alcohol Clin Exp Res"},{"key":"286_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1440-1746.2005.04220.x","volume":"21","author":"R Kirsch","year":"2006","unstructured":"Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la M, Hall P: Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol. 2006, 21: 174-82.","journal-title":"J Gastroenterol Hepatol"},{"key":"286_CR43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.metabol.2005.07.015","volume":"55","author":"DA Patel","year":"2006","unstructured":"Patel DA, Srinivasan SR, Xu JH, Li S, Chen W, Berenson GS: Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metabolism. 2006, 55: 699-705.","journal-title":"Metabolism"},{"key":"286_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation. 2003, 107: 391-7.","journal-title":"Circulation"},{"key":"286_CR45","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/j.1572-0241.2006.00719.x","volume":"101","author":"H Kang","year":"2006","unstructured":"Kang H, Greenson JK, Omo JT, Chao C, Peterman D, Anderson L, Foess-Wood L, Sherbondy MA, Conjeevaram HS: Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol. 2006, 101: 2247-53.","journal-title":"Am J Gastroenterol"},{"key":"286_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.ATV.0000252126.48375.d5","volume":"27","author":"K Inoue","year":"2007","unstructured":"Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T: Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2007, 27: 161-7.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"286_CR47","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","volume":"96","author":"P Rovere","year":"2000","unstructured":"Rovere P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, Zimmermann VS, Garlanda C, Fascio U, Sabbadini MG, Rugarli C, Mantovani A, Manfredi AA: The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood. 2000, 96: 4300-6.","journal-title":"Blood"},{"key":"286_CR48","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0002-9440(10)61122-4","volume":"160","author":"DG Souza","year":"2002","unstructured":"Souza DG, Soares AC, Pinho V, Torloni H, Reis LF, Teixeira MM, Dias AA: Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol. 2002, 160: 1755-65.","journal-title":"Am J Pathol"},{"key":"286_CR49","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.atherosclerosis.2007.05.031","volume":"197","author":"N Kotooka","year":"2008","unstructured":"Kotooka N, Inoue T, Fujimatsu D, Morooka T, Hashimoto S, Hikichi Y, Uchida T, Sugiyama A, Node K: Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening. Atherosclerosis. 2008, 197: 368-74.","journal-title":"Atherosclerosis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-8-53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-8-53\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-8-53","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-8-53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T20:43:26Z","timestamp":1738529006000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-8-53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,14]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-8-53","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,14]]},"assertion":[{"value":"17 June 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"53"}}